WHO Guidelines about Mental Health Gap Action Programme (mhGAP) for mental, neurological and substance use disorders: Review and Comments

Alexandros Argyriadis, Agathi Argyriadi
{"title":"WHO Guidelines about Mental Health Gap Action Programme (mhGAP) for mental, neurological and substance use disorders: Review and Comments","authors":"Alexandros Argyriadis, Agathi Argyriadi","doi":"10.30574/wjbphs.2024.17.2.0086","DOIUrl":null,"url":null,"abstract":"Introduction: The World Health Organization (WHO) has been instrumental in developing evidence-based guidelines to address mental, neurological, and substance use disorders through its Mental Health Gap Action Programme (mhGAP). These guidelines provide essential recommendations for healthcare professionals to deliver effective care in non-specialized health settings. Aim: This article aims to review and analyze the updated WHO guidelines on the mhGAP intervention for mental, neurological, and substance use disorders, focusing on their significance, content, and implications for clinical practice. Methods: A comprehensive review of the WHO documents published in 2023, including the \"mhGAP intervention guide for mental, neurological, and substance use disorders in non-specialized health settings\" and the \"Update of the Mental Health Gap Action Programme (mhGAP) guidelines for mental, neurological, and substance use disorders, 2015,\" was conducted. The review examines the scope of the guidelines, their recommendations, and the evidence supporting them. Results: The updated WHO guidelines cover a wide range of mental health conditions, including alcohol use disorders, anxiety disorders, depression, and more. Each guideline provides evidence-based recommendations for prevention, diagnosis, and treatment, with the aim of improving access to quality mental health care in diverse healthcare settings. The guidelines are freely accessible online through the WHO's mhGAP Evidence Resource Centre website, offering detailed evidence profiles and recommendations for healthcare professionals. Conclusions: The WHO guidelines on the mhGAP represent a critical resource for healthcare professionals worldwide, offering evidence-based guidance for the delivery of mental health care. By providing standardized recommendations informed by the best available evidence, these guidelines support the implementation of evidence-based practice and contribute to improved patient outcomes. The WHO's commitment to updating and disseminating these guidelines underscores its dedication to promoting mental health equity and advancing evidence-based care globally.","PeriodicalId":23738,"journal":{"name":"World Journal of Biology Pharmacy and Health Sciences","volume":"19 2","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-02-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"World Journal of Biology Pharmacy and Health Sciences","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.30574/wjbphs.2024.17.2.0086","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Introduction: The World Health Organization (WHO) has been instrumental in developing evidence-based guidelines to address mental, neurological, and substance use disorders through its Mental Health Gap Action Programme (mhGAP). These guidelines provide essential recommendations for healthcare professionals to deliver effective care in non-specialized health settings. Aim: This article aims to review and analyze the updated WHO guidelines on the mhGAP intervention for mental, neurological, and substance use disorders, focusing on their significance, content, and implications for clinical practice. Methods: A comprehensive review of the WHO documents published in 2023, including the "mhGAP intervention guide for mental, neurological, and substance use disorders in non-specialized health settings" and the "Update of the Mental Health Gap Action Programme (mhGAP) guidelines for mental, neurological, and substance use disorders, 2015," was conducted. The review examines the scope of the guidelines, their recommendations, and the evidence supporting them. Results: The updated WHO guidelines cover a wide range of mental health conditions, including alcohol use disorders, anxiety disorders, depression, and more. Each guideline provides evidence-based recommendations for prevention, diagnosis, and treatment, with the aim of improving access to quality mental health care in diverse healthcare settings. The guidelines are freely accessible online through the WHO's mhGAP Evidence Resource Centre website, offering detailed evidence profiles and recommendations for healthcare professionals. Conclusions: The WHO guidelines on the mhGAP represent a critical resource for healthcare professionals worldwide, offering evidence-based guidance for the delivery of mental health care. By providing standardized recommendations informed by the best available evidence, these guidelines support the implementation of evidence-based practice and contribute to improved patient outcomes. The WHO's commitment to updating and disseminating these guidelines underscores its dedication to promoting mental health equity and advancing evidence-based care globally.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
世卫组织关于精神、神经和药物使用失调的心理健康差距行动方案(mhGAP)指南:审查和评论
导言:世界卫生组织(WHO)通过其 "心理健康差距行动方案"(mhGAP),在制定以证据为基础的指南以应对精神、神经和药物使用障碍方面发挥了重要作用。这些指南为医护人员在非专业医疗机构提供有效护理提供了重要建议。目的:本文旨在回顾和分析最新的世界卫生组织精神、神经和药物使用障碍 mhGAP 干预指南,重点关注其意义、内容和对临床实践的影响。研究方法对2023年出版的世卫组织文件进行了全面回顾,包括《精神、神经和物质使用障碍在非专业医疗机构的mhGAP干预指南》和《2015年精神、神经和物质使用障碍的精神卫生差距行动方案(mhGAP)指南更新》。该综述研究了指南的范围、建议以及支持这些建议的证据。结果:更新后的世卫组织指南涵盖了广泛的精神健康状况,包括酒精使用障碍、焦虑症、抑郁症等。每份指南都为预防、诊断和治疗提供了基于证据的建议,目的是改善在不同医疗环境中获得优质精神卫生保健的机会。这些指南可通过世卫组织的 mhGAP 证据资源中心网站免费在线查阅,为医疗保健专业人员提供详细的证据简介和建议。结论:世卫组织关于 mhGAP 的指南是全球医疗保健专业人员的重要资源,为提供心理保健服务提供了循证指导。通过提供以现有最佳证据为依据的标准化建议,这些指南为循证实践的实施提供了支持,并有助于改善患者的治疗效果。世卫组织致力于更新和传播这些指南,这凸显了世卫组织在全球范围内促进心理健康公平和推进循证护理的决心。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Computational strategies for drug discovery: Harnessing Indian medicinal plants A narrative review of pharmacological and phytochemical properties of decorative flowering plants at Hyde Park Zoo Sanctuary and Tropical Gardens Inc., Guyana Recent updates on the safety of neurosurgery during the COVID-19 pandemic Development and characterization of Decitabine Niosomes Attachment style and relationship satisfaction among early adults
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1